Tamas Kovacs, Ph.D.

CEO & Head of Research
Biopesticide Ltd. Enviroinvest Corp.
  • SkillsSenior microbiology scientist with company leading experineces
  • ExpertiseBacteriophages, biopesticides, financial source aquistion

Biopesticide Ltd., CEO, 2018 – Present

Enviroinvest Corp., Deputy CEO, Head of Nanophagetherapy Centre (private research institute), 2010 – Present

Rolfim Ltd., Managing president, 2004 – 2005

Enviroinvest Ltd, R&D director, Head of R&D laboratory, 2002 – 2010

Enviroinvest Ltd., Area Manager (Budapest – Szeged), 2000 – 2002

Linde Gas Hungary Ltd., Gas Cartridge Appliance Microbiologist, 1999 – 2000

Ekofutur Ltd., Head of Co., 1997 – 2002

Tisza Natura Consulting Company, Office manager, 1995-1997

Biopesticide Ltd., CEO, 2018 – Present

Enviroinvest Corp., Deputy CEO, Head of Nanophagetherapy Centre (private research institute), 2010 – Present

Rolfim Ltd., Managing president, 2004 – 2005

Enviroinvest Ltd, R&D director, Head of R&D laboratory, 2002 – 2010

Enviroinvest Ltd., Area Manager (Budapest – Szeged), 2000 – 2002

Linde Gas Hungary Ltd., Gas Cartridge Appliance Microbiologist, 1999 – 2000

Ekofutur Ltd., Head of Co., 1997 – 2002

Tisza Natura Consulting Company, Office manager, 1995-1997

Biopesticide Ltd., CEO, 2018 – Present

Enviroinvest Corp., Deputy CEO, Head of Nanophagetherapy Centre (private research institute), 2010 – Present

Rolfim Ltd., Managing president, 2004 – 2005

Enviroinvest Ltd, R&D director, Head of R&D laboratory, 2002 – 2010

Enviroinvest Ltd., Area Manager (Budapest – Szeged), 2000 – 2002

Linde Gas Hungary Ltd., Gas Cartridge Appliance Microbiologist, 1999 – 2000

Ekofutur Ltd., Head of Co., 1997 – 2002

Tisza Natura Consulting Company, Office manager, 1995-1997

Send a message

1 + 4 =

Bacteriophage-Mediated Control of Phytopathogenic Xanthomonads: A Promising Green Solution for the Future

Xanthomonads, members of the family Xanthomonadaceae, are economically important plant pathogenic bacteria responsible for infections of over 400 plant species. Bacteriophage-based biopesticides can provide an environmentally friendly, effective solution to control...

Isolation and Characterization of a Novel Lytic Bacteriophage against the K2 Capsule-Expressing Hypervirulent Klebsiella pneumoniae Strain 52145, and Identification of Its Functional Depolymerase

Klebsiella pneumoniae is among the leading bacteria that cause nosocomial infections. The capsule of this Gram-negative bacterium is a dominant virulence factor, with a prominent role in defense and biofilm formation. Bacteriophages, which are specific for one...

Isolation of a Novel Lytic Bacteriophage against a Nosocomial Methicillin-Resistant Staphylococcus aureus Belonging to ST45

Abstract Methicillin-resistant Staphylococcus aureus (MRSA) can cause a wide range of infections from mild to life-threatening conditions. Its enhanced antibiotic resistance often leads to therapeutic failures and therefore alternative eradication methods must be...